Alkermes PLC logo

Alkermes PLC

1
NAS:ALKS (Ireland)   Ordinary Shares
$ 29.65 +0.15 (+0.51%) 11:08 PM EST
15.13
P/B:
3.69
Volume:
417.11K
Avg Vol (2M):
1.83M
Trade In:
Volume:
417.11K
Avg Vol (2M):
1.83M

Business Description

Alkermes PLC logo
Alkermes PLC
NAICS : 325412 SIC : 2834
ISIN : IE00B56GVS15

Share Class Description:

ALKS: Ordinary Shares
Description
Alkermes PLC is a fully integrated biotechnology company that applies its proprietary technologies to research, develop, and commercialize pharmaceutical products designed for unmet medical needs in therapeutic areas. The company utilizes several to develop and commercialize products and, in so doing, access technological, financial, marketing, manufacturing, and other resources. Alkermes either purchases active drug products from third parties or receives them from its third-party licensees to formulate products using its technologies. It operates in U.S., which derives maximum revenue, Ireland and Rest of the world.
Name Current Vs Industry Vs History
Cash-To-Debt 2.48
Equity-to-Asset 0.6
Debt-to-Equity 0.28
Debt-to-EBITDA 0.92
Interest Coverage 13.03
Piotroski F-Score 7/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score 4.45
Distress
Grey
Safe
Beneish M-Score -2.5
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC
Name Current Vs Industry Vs History
5-Day RSI 32.07
9-Day RSI 43.01
14-Day RSI 49.09
6-1 Month Momentum % 16.85
12-1 Month Momentum % 3.08

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 3.45
Quick Ratio 3.03
Cash Ratio 2
Days Inventory 277.42
Days Sales Outstanding 78.41
Days Payable 107.05

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -1.6
Shareholder Yield % 0.38

Financials (Next Earnings Date:2025-02-14 Est.)

ALKS's 30-Y Financials
Income Statement Breakdown FY
No Enough Data
Balance Sheet Breakdown
No Enough Data
Cashflow Statement Breakdown
No Enough Data

Historical Operating Revenue by Business Segment

Historical Operating Revenue by Geographic Region

5-Step DuPont Analysis as of
No Enough Data

Guru Trades

See Details
To

Insider Trades

See Details
To

Gurus Latest Trades with NAS:ALKS

No Available Data

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
Log
Bar
To

Annualized Return %  

Symbol
1 Week
1 Month
3 Months
6 Months
YTD
1 Year
3 Years
5 Years
10 Years

Total Annual Return %  

Symbol
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015

Alkermes PLC Executives

Details

Valuation Chart

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $) 1,505.121
EPS (TTM) ($) 1.95
Beta 0.32
Volatility % 31.47
14-Day RSI 49.09
14-Day ATR ($) 0.83827
20-Day SMA ($) 30.2165
12-1 Month Momentum % 3.08
52-Week Range ($) 22.9 - 32.88
Shares Outstanding (Mil) 161.8

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 7
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Alkermes PLC Filings

Filing Date Document Date Form
No Filing Data

Alkermes PLC Stock Events

Financials Calendars
Event Date Price($)
No Event Data

Alkermes PLC Frequently Asked Questions

What is Alkermes PLC(ALKS)'s stock price today?
The current price of ALKS is $29.65. The 52 week high of ALKS is $32.88 and 52 week low is $22.90.
When is next earnings date of Alkermes PLC(ALKS)?
The next earnings date of Alkermes PLC(ALKS) is 2025-02-14 Est..
Does Alkermes PLC(ALKS) pay dividends? If so, how much?
Alkermes PLC(ALKS) does not pay dividend.

Press Release

Subject Date
No Press Release

Headlines

See More
  • 1
No news.
  • 1